FOXO Technologies Inc.(FOXO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

FOXO FOXO Technologies Inc.

Trading 08-10 09:31:00 EDT Delay

{"stockData":{"symbol":"FOXO","market":"US","secType":"STK","nameCN":"FOXO Technologies Inc.","latestPrice":0.0799,"timestamp":1786368660987,"preClose":0.0799,"halted":0,"volume":703,"delay":15,"changeRate":0,"floatShares":1420412,"shares":1420412,"eps":-1589.2933,"marketStatus":"Trading","change":0,"latestTime":"08-10 09:31:00 EDT Delay","open":0.0799,"high":0.0799,"low":0.0799,"amount":56.111470000000004,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1589.2933,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1786392000000},"marketStatusCode":2,"adr":0,"listingDate":1611896400000,"exchange":"PINK","adjPreClose":0.0799,"volumeRatio":0.077065},"requestUrl":"/m/hq/s/FOXO","defaultTab":"news","newsList":[{"id":"2655310898","title":"FOXO Unit Vector BioSource Agrees to Buy Four Grifols Blood Collection Centers in US Asset Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2655310898","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655310898?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:33","pubTimestamp":1785328393,"startTime":"0","endTime":"0","summary":"FOXO unit Vector BioSource agrees to buy four Grifols blood collection centers in US asset dealFOXO’s Vector BioSource signed a definitive agreement to buy assets tied to four U.S. blood collection ce","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nNDL6FHzB9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4585","BK4112","FOXOD","IE00BN0W2W23.USD","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014021.USD","SG9999014039.USD","IE00BN0W2V16.EUR","BK4588","BCDF","SG9999014005.SGD","IE00B64PRP62.GBP","BK4023","NDAQ","LU0314104364.USD","SG9999014013.SGD","IE00BGHQF748.EUR","FOXO","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655077860","title":"Foxo Technologies Inc.’s Subsidiary Vector Biosource, Inc. Enters into Definitive Agreement to Acquire Four Blood Collection Centers from Grifols Bio Supplies, Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2655077860","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655077860?lang=en_us&edition=fundamental","pubTime":"2026-07-29 20:30","pubTimestamp":1785328200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nTUA12DJC2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4023","FOXOD","FOXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654802857","title":"FOXO Unit Vector BioSource Agrees to Buy Four Grifols Blood Collection Centers for $3.5 Million Plus up to $1 Million Earnout","url":"https://stock-news.laohu8.com/highlight/detail?id=2654802857","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654802857?lang=en_us&edition=fundamental","pubTime":"2026-07-28 04:16","pubTimestamp":1785183409,"startTime":"0","endTime":"0","summary":"FOXO unit Vector BioSource agrees to buy four Grifols blood collection centers for $3.5 million plus up to $1 million earnoutFOXO Technologies unit Vector BioSource agreed to buy assets tied to four G","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL41WHs5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"FOXO Unit Vector BioSource Agrees to Buy Four Grifols Blood Collection Centers for $3.5 Million Plus up to $1 Million Earnout","news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","FOXO","FOXOD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648351080","title":"FOXO Technologies Completes 1-for-3,000 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2648351080","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648351080?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:30","pubTimestamp":1782905428,"startTime":"0","endTime":"0","summary":"FOXO Technologies completes 1-for-3,000 reverse stock splitFOXO Technologies completed a 1-for-3,000 reverse stock split effective 4:01 p.m. ET June 30, 2026.Shares begin trading split-adjusted on the","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nNDL8HppbG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014039.USD","BK4585","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU0314104364.USD","IE00BKPKM429.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","LU2210150020.SGD","BK4588","LU2210149790.SGD","FOXO","SG9999014021.USD","IE00BN0W2W23.USD","LU2095319765.USD","SG9999014013.SGD","NDAQ","IE00BN0W2T93.GBP","BK4112","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648108695","title":"Foxo Technologies Inc. Announces Completion of Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2648108695","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648108695?lang=en_us&edition=fundamental","pubTime":"2026-07-01 19:30","pubTimestamp":1782905400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260701:nTUA9RWYYZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FOXO","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640790727","title":"FOXO board, majority holder authorize reverse stock split up to 1-for-10,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2640790727","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640790727?lang=en_us&edition=fundamental","pubTime":"2026-06-03 21:54","pubTimestamp":1780494867,"startTime":"0","endTime":"0","summary":"FOXO Technologies’ board unanimously adopted a reverse stock split proposal at a May 13, 2026 special meeting.Majority shareholder Rennova Health delivered written consent on May 18, 2026, backing the action with 95.56% of voting power.Plan authorizes a reverse split of Class A common stock within a 1-for-1,000 to 1-for-10,000 range, with the final ratio set by the board.Company targets effectiveness at least 20 days after the information statement mailing, with a latest filing deadline of Nov. 30, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securit","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL1mhfpj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOXO","BK4023","BK4185","RNVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639614774","title":"FOXO licenses epigenetics platform in new strategic partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2639614774","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639614774?lang=en_us&edition=fundamental","pubTime":"2026-05-29 07:03","pubTimestamp":1780009382,"startTime":"0","endTime":"0","summary":"FOXO Technologies ( ($FOXO) ) just unveiled an announcement. On May 27, 2026, FOXO Technologies and its FOXO Labs subsidiary entered a strategic te...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/foxo-licenses-epigenetics-platform-in-new-strategic-partnership?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/foxo-licenses-epigenetics-platform-in-new-strategic-partnership?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FOXO","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638932226","title":"FOXO Technologies licenses epigenetics platform to LongevityFP in exclusive partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2638932226","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638932226?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:34","pubTimestamp":1779971648,"startTime":"0","endTime":"0","summary":"FOXO Technologies entered an exclusive license partnership with LongevityFP Technologies to commercialize its epigenetics underwriting technology.LongevityFP will pay a 3% royalty on net revenue, capped at USD 1.3 million.Deal grants LongevityFP a 10-year option to acquire majority ownership of FOXO Labs, which holds the epigenetics IP.If exercised, FOXO would retain a 40% equity interest in the resulting epigenetics enterprise.Agreement reunites the platform with inventor Jon R. Sabes, former FOXO CEO, while FOXO shifts focus to healthcare services operations.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL7LT1Q7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","FOXO","LU2210150020.SGD","SG9999014021.USD","BK4112","IE00BKPKM429.USD","IE00BGHQF748.EUR","IE00BN0W2W23.USD","IE00B64PRP62.GBP","SG9999014005.SGD","SG9999014039.USD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","BK4023","LU2095319765.USD","NDAQ","LU0314104364.USD","BK4588","SG9999014013.SGD","LU2210149790.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638693478","title":"Foxo Technologies, Inc., Forms Strategic Partnership With Longevityfp Technologies, Llc. to Commercialize Foxo’s Epigenetics Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2638693478","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638693478?lang=en_us&edition=fundamental","pubTime":"2026-05-28 20:33","pubTimestamp":1779971580,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUA8NQSRJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4023","FOXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637340573","title":"FOXO Technologies Shareholders Approve Major Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2637340573","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637340573?lang=en_us&edition=fundamental","pubTime":"2026-05-23 07:40","pubTimestamp":1779493248,"startTime":"0","endTime":"0","summary":"FOXO Technologies ( ($FOXO) ) just unveiled an update. On May 15, 2026, FOXO Technologies Inc. entered into a settlement with J.H. Darbie & Co. to ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/foxo-technologies-shareholders-approve-major-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/foxo-technologies-shareholders-approve-major-reverse-stock-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FOXO","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637876663","title":"FOXO Technologies files draft information statement on reverse stock split plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2637876663","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637876663?lang=en_us&edition=fundamental","pubTime":"2026-05-21 05:28","pubTimestamp":1779312484,"startTime":"0","endTime":"0","summary":"FOXO Technologies shareholders authorized an amendment to the company’s certificate of incorporation to permit a reverse stock split of its Class A common stock at a ratio ranging from 1-for-1,000 to 1-for-10,000, with the final ratio set by the board.The board can implement the reverse split at any time before Nov. 30, 2026, or abandon it before filing the amendment.The move targets a higher per-share price from a stock that closed at USD 0.0001 on May 18, 2026, supporting a potential OTCQB quotation or an exchange uplisting effort.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval syste","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL5W38fY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOXO","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636020790","title":"FOXO exchanges Series A preferred stock for USD 7.78 million senior notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2636020790","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636020790?lang=en_us&edition=fundamental","pubTime":"2026-05-18 19:32","pubTimestamp":1779103920,"startTime":"0","endTime":"0","summary":"FOXO Technologies entered exchange agreements on May 12, 2026 to swap all outstanding Series A Cumulative Convertible Redeemable Preferred Stock held by two institutional investors for senior unsecured non-convertible promissory notes totaling USD 7.78 million.Investor 1 exchanged 2,467 preferred shares with stated value of USD 2.47 million for a senior note in the same principal amount; Investor 2 exchanged 5,307 preferred shares with stated value of USD 5.31 million for a senior note in the same principal amount.The preferred shares were cancelled, removing the investors’ conversion rights to company equity.The notes are non-interest bearing, mature on May 12, 2027 unless earlier accelerated on default; default interest accrues at 18%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be inter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260518:nNDL3m908k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","FOXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635353570","title":"FOXO net loss widens to $1.45 million in Q1 FY26; net revenues rise 63.03% to $5.17 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635353570","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635353570?lang=en_us&edition=fundamental","pubTime":"2026-05-15 22:59","pubTimestamp":1778857161,"startTime":"0","endTime":"0","summary":"FOXO Technologies posted net revenues of 5.17 million for the three months ended March 31, 2026, up 63.03%, while operating loss narrowed to 276,851.Net loss attributable to shareholders widened to 1.45 million, while interest expense climbed to 973,135 on higher borrowings and 0.4 million of default penalties and interest.Healthcare segment swung to income of 296,914 on net revenues of 4.8 million, while Life Science Services reported net revenues of 361,250 and segment income of 142,416 following the Vector acquisition.Cash fell to 65,896 as of March 31, 2026, while working capital deficit widened to 27.07 million and total debt rose to 8.61 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDLb0H9J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOXO","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629001779","title":"FOXO Technologies to raise authorized shares to 25,020,000,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2629001779","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629001779?lang=en_us&edition=fundamental","pubTime":"2026-04-21 05:28","pubTimestamp":1776720504,"startTime":"0","endTime":"0","summary":"FOXO Technologies filed a charter amendment to raise authorized capital stock to 25,020,000,000 shares.Authorization now includes 25,000,000,000 shares of Class A common stock.Amendment effective May 3, 2026, upon filing with Delaware secretary of state.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 20, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL2h7ZdG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOXO","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627236022","title":"FOXO net loss to common stockholders widens to $34.1 million in FY25; revenue more than tripled to $16.4 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627236022","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627236022?lang=en_us&edition=fundamental","pubTime":"2026-04-16 00:19","pubTimestamp":1776269955,"startTime":"0","endTime":"0","summary":"FOXO posted fiscal 2025 net loss attributable to FOXO of $12.4 million, little changed from prior year.Operating loss widened to $10.3 million, driven by a $7 million goodwill impairment.Adjusted EBITDA loss narrowed to $4 million from $6.6 million.Management said liquidity remains strained, expecting current cash and operating cash flow to be insufficient to fund operations through 12 months ended Dec. 31, 2026 without additional financing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 15, 2026, and is solely r","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL9kZyPf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","FOXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627463672","title":"FOXO plans to raise authorized Class A shares to 25 billion via written consent","url":"https://stock-news.laohu8.com/highlight/detail?id=2627463672","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627463672?lang=en_us&edition=fundamental","pubTime":"2026-04-14 03:55","pubTimestamp":1776110158,"startTime":"0","endTime":"0","summary":"FOXO board adopted, by unanimous written consent on March 20, 2026, a charter amendment to expand authorized Class A common stock.Majority shareholder Rennova Health delivered written consent on March 27, 2026, providing stockholder authorization for increase in authorized Class A common shares to 25,000,000,000 from 10,000,000,000.Board cited need to cover potential conversions of preferred stock and convertible debt, support future equity-linked financing, support strategic transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchang","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260413:nNDL8Rqcyf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNVA","FOXO","BK4023","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624568569","title":"FOXO Technologies Expands Authorized Class A Share Capacity","url":"https://stock-news.laohu8.com/highlight/detail?id=2624568569","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624568569?lang=en_us&edition=fundamental","pubTime":"2026-04-03 00:28","pubTimestamp":1775147302,"startTime":"0","endTime":"0","summary":"FOXO Technologies ( ($FOXO) ) has provided an announcement. On March 27, 2026, FOXO Technologies’ majority stockholder, Rennova Health, approved by...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/foxo-technologies-expands-authorized-class-a-share-capacity?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/foxo-technologies-expands-authorized-class-a-share-capacity?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","FOXO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624545555","title":"FOXO Technologies files draft information statement for 25 billion-share authorization increase","url":"https://stock-news.laohu8.com/highlight/detail?id=2624545555","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624545555?lang=en_us&edition=fundamental","pubTime":"2026-04-02 02:14","pubTimestamp":1775067260,"startTime":"0","endTime":"0","summary":"FOXO Technologies shareholders authorized an amendment to certificate of incorporation to raise authorized Class A common shares to 25,000,000,000 from 10,000,000,000.Board set March 20, 2026 as record date for information statement.Outstanding Class A common shares totaled 3,732,660,939 as of record date.Company cited need to support conversions of preferred stock, convertible debt, warrants tied to trading price, while preserving flexibility for future equity-linked financings.Expanded authorization could increase dilution risk for existing holders through future issuances tied to conversions or capital raising.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL1PJss:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOXO","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624550294","title":"FOXO delays annual report filing as auditors complete review of financial statements","url":"https://stock-news.laohu8.com/highlight/detail?id=2624550294","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624550294?lang=en_us&edition=fundamental","pubTime":"2026-04-01 09:48","pubTimestamp":1775008127,"startTime":"0","endTime":"0","summary":"FOXO Technologies filed notice it will miss deadline for fiscal 2025 annual report on Form 10-K for period ended Dec. 31, 2025.Delay reflects ongoing completion of Form 10-K, with auditors not finished with audit review of year-end financial statements.Company expects to file report by 15th calendar day after prescribed due date.Notice indicated no anticipated significant change in results of operations versus prior-year period.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FOXO Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 31, 2026, and is solely responsible fo","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL59PC8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FOXO","BK4023"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624151550","title":"FOXO Technologies Delays Annual 10-K Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2624151550","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624151550?lang=en_us&edition=fundamental","pubTime":"2026-04-01 09:36","pubTimestamp":1775007414,"startTime":"0","endTime":"0","summary":"FOXO Technologies ( ($FOXO) ) has released a notification of late filing. FOXO Technologies Inc. has filed a Form 12b-25 to notify investors of a d...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/foxo-technologies-delays-annual-10-k-filing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/foxo-technologies-delays-annual-10-k-filing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4023","FOXO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.foxotechnologies.com","description":"FOXO Technologies Inc. engages in epigenetic biomarker underwriting technology and consumer engagement platform service business in the United States. It operates through two segments, FOXO Labs and FOXO Life. The company applies automated machine learning and artificial intelligence technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and FOXO Life, a sales and distribution platform focused on recruiting independent life insurance agents to sell life insurance with the Longevity Report. The company was founded in 2020 and is based in Minneapolis, Minnesota. FOXO Technologies Inc. is a subsidiary of FOXO Management LLC.","exchange":"PINK","name":"FOXO Technologies Inc.","nameEN":"FOXO Technologies Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"FOXO Technologies Inc.(FOXO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest FOXO Technologies Inc.(FOXO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"FOXO Technologies Inc.,FOXO,FOXO Technologies Inc.股票,FOXO Technologies Inc.股票老虎,FOXO Technologies Inc.股票老虎国际,FOXO Technologies Inc.行情,FOXO Technologies Inc.股票行情,FOXO Technologies Inc.股价,FOXO Technologies Inc.股市,FOXO Technologies Inc.股票价格,FOXO Technologies Inc.股票交易,FOXO Technologies Inc.股票购买,FOXO Technologies Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"FOXO Technologies Inc.(FOXO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest FOXO Technologies Inc.(FOXO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}